A first in disease trial of the safety, tolerability, and anti-seizure effects of ES-481 in drug-resistant epilepsy.

Foster EC et al.

NCBI PubMed Central · Papers · License: Open Access

consciousness neuroscience

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 396200
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.